AxoGen Locks In $17 Million Investment from Essex Woodlands
AxoGen Inc. (NSDQ:AXGN) said today it sold 4.8 million shares to investment firm Essex Woodlands, reeling in $17.1 million for Axogen and giving Essex Woodlands a 16% stake in the company.
The funds from the sale are slated to support market growth and accelerate the company’s entry into new nerve repair markets, including the development and commercialization of new nerve repair products.
“Our partnership with Essex Woodlands puts AxoGen in an excellent position to build on the momentum we are generating in the nerve repair market as well as capitalize on our numerous opportunities.
Help employers find you! Check out all the jobs and post your resume.
The funds from the sale are slated to support market growth and accelerate the company’s entry into new nerve repair markets, including the development and commercialization of new nerve repair products.
“Our partnership with Essex Woodlands puts AxoGen in an excellent position to build on the momentum we are generating in the nerve repair market as well as capitalize on our numerous opportunities.
Help employers find you! Check out all the jobs and post your resume.